PDPN
PDPN (podoplanin, also known as T1A-2, Gp38, aggrus, GP40, PA2.26 and D2-40) is a type-I integral membrane glycoprotein that mediates cell migration and adhesion through a range of protein partners. It has roles in vessel development, lymph node biology and tumour cell invasiveness. Browse Assay Genie's current range of PDPN research reagents below, or read on for the biology behind the target.
PDPN mediates effects on cell migration and adhesion through its different partners. During development it contributes to the separation of blood and lymphatic vessels by binding CLEC1B, which activates platelets and can lead to aggregation; interaction with CD9 attenuates this PDPN-induced platelet aggregation. Through MSN or EZR, PDPN promotes epithelial-mesenchymal transition, leading to ERM phosphorylation and RHOA activation, which increases migration and invasiveness. Its interaction with CD44 promotes directional migration in epithelial and tumour cells, and binding to LGALS8 may help connect the lymphatic endothelium to the surrounding extracellular matrix.
In lymph nodes, PDPN controls the adhesion of fibroblastic reticular cells to the extracellular matrix and actomyosin contraction by maintaining ERM protein and MYL9 activation. Engagement of CLEC1B by PDPN promotes relaxation of these cells. In keratinocytes, PDPN produces an elongated shape, numerous membrane protrusions, actin reorganisation, increased motility and reduced adhesion. In tumour cells it controls invadopodia stability and maturation through RHOC, ROCK1/ROCK2, LIMK1/LIMK2 and CFL1, supporting efficient matrix degradation. It is also required for normal lung cell proliferation and alveolus formation at birth. It does not act as a water channel or aquaporin regulator, and does not affect folic acid or amino acid transport.
The PDPN gene encodes a type-I integral membrane glycoprotein of the podoplanin family, with diverse distribution in human tissues. NCBI notes that its physiological function may relate to its mucin-type character, that homologues in other species have been described as a differentiation antigen and influenza-virus receptor, and that it has been proposed as a marker of lung injury. Alternatively spliced transcript variants encode different isoforms. The protein localises to the membrane, including lamellipodia, filopodia, microvilli, ruffles, invadopodia and membrane rafts.
PDPN contributes to the separation of blood and lymphatic vessels through CLEC1B binding, and may link lymphatic endothelium to the extracellular matrix via LGALS8.
PDPN promotes epithelial-mesenchymal transition and invadopodia maturation through ERM proteins, RHOA and RHOC signalling, increasing migration and matrix degradation.
PDPN binding to CLEC1B can trigger platelet activation or aggregation, while interaction with CD9 attenuates it.
PDPN controls fibroblastic reticular cell adhesion and actomyosin contraction by maintaining ERM protein and MYL9 activation.
PDPN mediates cell migration and adhesion through partners such as CLEC1B, CD9, CD44, MSN and EZR. It contributes to blood and lymphatic vessel separation, controls fibroblastic reticular cell behaviour in lymph nodes, and supports invadopodia function in tumour cells. It is also required for alveolus formation at birth.
PDPN stands for podoplanin and is also known as T1A-2, Gp38, aggrus, GP40, PA2.26 and D2-40. NCBI reports that alternatively spliced transcript variants encode different isoforms. These names appear in the literature, so searching with several aliases is useful.
Yes. Mouse and rat both have a Pdpn ortholog. NCBI notes that homologous proteins in other species have been described as a differentiation antigen and influenza-virus receptor. Check the datasheet of any product for its validated reactivity.
Binding partners, cytoskeletal regulators and signalling proteins linked to PDPN in migration, adhesion and platelet activation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86YL7; product specifications from Assay Genie datasheets.